Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Biotech, Institute Partner on Gut Microbe Links to Parkinson’s

Gut microbes

Gut microbes cultured in an artistic design (Nicola Fawcett, Wikimedia Commons)

18 June 2018. Researchers from a biotechnology company and a research institute are starting a joint project to find treatments for Parkinson’s disease targeting bacteria in the gut. Financial and intellectual property aspects of the partnership between Axial Biotherapeutics Inc. in Boston, and . . . → Read More: Biotech, Institute Partner on Gut Microbe Links to Parkinson’s

Soil Microbes Yield Rich Antibiotic Sources

Researchers taking soil samples

A group of geo- and bioscience researchers analyzed microbes residing in soil under northern California and discovered many new potential sources of antibiotics, well beyond current sources. . . . → Read More: Soil Microbes Yield Rich Antibiotic Sources

Natural, Engineered Microbes Shown to Control Cholera

Distributing water hygiene kits

A combination of natural bacteria found in milk products and a synthetic variation of those microbes are shown in tests with lab mice to detect and prevent cholera infections. . . . → Read More: Natural, Engineered Microbes Shown to Control Cholera

Hospital Network Formed for Childhood Cancer Immunotherapies

T-cells illustration

A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer. . . . → Read More: Hospital Network Formed for Childhood Cancer Immunotherapies

$850M Deal Kicks Off RNA Vaccine Research

RNA strand illustration

Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA. . . . → Read More: $850M Deal Kicks Off RNA Vaccine Research

NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Sickle cell illustration

The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease. . . . → Read More: NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell

Single Technology Produces Vaccines for Multiple Infectious Diseases

Ebola diagnostics

A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases. . . . → Read More: Single Technology Produces Vaccines for Multiple Infectious Diseases

Bacterial Genome Recoded to Produce Stable Protein Drugs

E. coli bacteria

A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods. . . . → Read More: Bacterial Genome Recoded to Produce Stable Protein Drugs

Stem Cell Transplants Found Safe for Spinal Cord Injuries

Spine model

Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases